Literature DB >> 2010436

Cell regulation by sphingosine and more complex sphingolipids.

A H Merrill1.   

Abstract

Sphingolipids have the potential to regulate cell behavior at essentially all levels of signal transduction. They serve as cell surface receptors for cytoskeletal proteins, immunoglobulins, and some bacteria; as modifiers of the properties of cell receptors for growth factors (and perhaps other agents); and as activators and inhibitors of protein kinases, ion transporters, and other proteins. Furthermore, the biological activity of these compounds resides not only in the more complex species (e.g., sphingomyelin, cerebrosides, gangliosides, and sulfatides), but also in their turnover products, such as the sphingosine backbone which inhibits protein kinase C and activates the EGF-receptor kinase, inter alia. Since sphingolipids change with cell growth, differentiation, and neoplastic transformation, they could be vital participants in the regulation of these processes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010436     DOI: 10.1007/bf00768840

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  134 in total

1.  Protein kinase C inhibition by sphingoid long-chain bases: effects on secretion in human neutrophils.

Authors:  E Wilson; W G Rice; J M Kinkade; A H Merrill; R R Arnold; J D Lambeth
Journal:  Arch Biochem Biophys       Date:  1987-11-15       Impact factor: 4.013

2.  Inhibitors of protein kinase C prevent enhancement of calcium current and action potentials in peptidergic neurons of Aplysia.

Authors:  P J Conn; J A Strong; L K Kaczmarek
Journal:  J Neurosci       Date:  1989-02       Impact factor: 6.167

3.  Biphasic response of Na+-dependent amino acid transport to tumor promoting phorbol esters in cultured renal epithelial cells, LLC-PK1.

Authors:  W D Dawson; J S Cook
Journal:  Prog Clin Biol Res       Date:  1988

4.  Inhibition of the oxidative burst in human neutrophils by sphingoid long-chain bases. Role of protein kinase C in activation of the burst.

Authors:  E Wilson; M C Olcott; R M Bell; A H Merrill; J D Lambeth
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

5.  Dexamethasone increases neutral sphingomyelinase activity and sphingosine levels in 3T3-L1 fibroblasts.

Authors:  C K Ramachandran; D K Murray; D H Nelson
Journal:  Biochem Biophys Res Commun       Date:  1990-03-16       Impact factor: 3.575

6.  Tumor-promoter-resistant cells lack trisialoganglioside response.

Authors:  L Srinivas; T D Gindhart; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  Alteration of glycolipids in ras-transfected NIH 3T3 cells.

Authors:  G R Matyas; S A Aaronson; R O Brady; P H Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Gangliosides as bimodal regulators of cell growth.

Authors:  S Spiegel; P H Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

9.  Phospholipid functional groups involved in protein kinase C activation, phorbol ester binding, and binding to mixed micelles.

Authors:  M H Lee; R M Bell
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

10.  Mitogenesis of 3T3 fibroblasts induced by endogenous ganglioside is not mediated by cAMP, protein kinase C, or phosphoinositides turnover.

Authors:  S Spiegel; C Panagiotopoulos
Journal:  Exp Cell Res       Date:  1988-08       Impact factor: 3.905

View more
  31 in total

1.  Screening of fungal species for fumonisin production and fumonisin-like disruption of sphingolipid biosynthesis.

Authors:  W P Norred; C W Bacon; R T Riley; K A Voss; F I Meredith
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  A novel approach for preventing esophageal stricture formation: sphingosylphosphorylcholine-enhanced tissue remodeling.

Authors:  Aydin Yagmurlu; Burhan Aksu; Meltem Bingol-Kologlu; Nurten Renda; Gulcin Altinok; Suat Fitoz; I Haluk Gokcora; Huseyin Dindar
Journal:  Pediatr Surg Int       Date:  2004-10       Impact factor: 1.827

3.  In vitro toxicology of fumonisins and the mechanistic implications.

Authors:  W P Norred; E Wang; H Yoo; R T Riley; A H Merrill
Journal:  Mycopathologia       Date:  1992-02       Impact factor: 2.574

Review 4.  Rafts as missing link between multidrug resistance and sphingolipid metabolism.

Authors:  J W J Hinrichs; K Klappe; J W Kok
Journal:  J Membr Biol       Date:  2005-01       Impact factor: 1.843

5.  A novel sphingophosphonolipid head group 1-hydroxy-2-aminoethyl phosphonate in Bdellovibrio stolpii.

Authors:  Y Watanabe; M Nakajima; T Hoshino; K Jayasimhulu; E E Brooks; E S Kaneshiro
Journal:  Lipids       Date:  2001-05       Impact factor: 1.880

Review 6.  Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.

Authors:  Hui Chen; Annie Y Chan; Donald U Stone; Nawajes A Mandal
Journal:  Surv Ophthalmol       Date:  2013-09-05       Impact factor: 6.048

7.  Suppressor gene analysis reveals an essential role for sphingolipids in transport of glycosylphosphatidylinositol-anchored proteins in Saccharomyces cerevisiae.

Authors:  M Skrzypek; R L Lester; R C Dickson
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

8.  Sphingolipid Long-Chain Base Synthesis in Plants (Characterization of Serine Palmitoyltransferase Activity in Squash Fruit Microsomes).

Authors:  D. V. Lynch; S. R. Fairfield
Journal:  Plant Physiol       Date:  1993-12       Impact factor: 8.340

9.  Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements.

Authors:  W M Holleran; W N Gao; K R Feingold; P M Elias
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 10.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.